Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vancol Industries

This article was originally published in The Tan Sheet

Executive Summary

Labeling for five products sold by the Denver, Colo.-based company make disease claims and are thus unapproved new drugs, FDA charges in Oct. 1 warning letter. Products at issue are Immunity Green Tea, Vitality Orange Pineapple, High Energy Citrus Punch, Potency Fruit Punch and Focus Watermelon Kiwi. Claims cited by FDA include "anticancer," "antidepressant," "antiviral," "antibacterial," "antiallergy" and "anti-inflammatory." The agency says the products are misbranded because labeling fails to include adequate directions for use and falsely suggests safety and effectiveness for their intended use. The company says it has not received the FDA letter
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090798

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel